These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9699654

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer.
    Cao S, Troutt AB, Rustum YM.
    Cancer Res; 1998 Apr 15; 58(8):1695-9. PubMed ID: 9563485
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium.
    Shinohara H, Killion JJ, Bucana CD, Yano S, Fidler IJ.
    Clin Cancer Res; 1999 Aug 15; 5(8):2148-56. PubMed ID: 10473099
    [Abstract] [Full Text] [Related]

  • 7. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen.
    Kurita A, Kado S, Matsumoto T, Asakawa N, Kaneda N, Kato I, Uchida K, Onoue M, Yokokura T.
    Cancer Chemother Pharmacol; 2011 Jan 15; 67(1):201-13. PubMed ID: 20354702
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide.
    Yang XX, Hu ZP, Chan SY, Duan W, Ho PC, Boelsterli UA, Ng KY, Chan E, Bian JS, Chen YZ, Huang M, Zhou SF.
    Curr Drug Metab; 2006 May 15; 7(4):431-55. PubMed ID: 16724931
    [Abstract] [Full Text] [Related]

  • 9. Nutritional modulation of antitumor efficacy and diarrhea toxicity related to irinotecan chemotherapy in rats bearing the ward colon tumor.
    Xue H, Sawyer MB, Field CJ, Dieleman LA, Baracos VE.
    Clin Cancer Res; 2007 Dec 01; 13(23):7146-54. PubMed ID: 18056195
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats.
    Takasuna K, Hagiwara T, Hirohashi M, Kato M, Nomura M, Nagai E, Yokoi T, Kamataki T.
    Cancer Res; 1996 Aug 15; 56(16):3752-7. PubMed ID: 8706020
    [Abstract] [Full Text] [Related]

  • 13. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
    Allegrini G, Goulette FA, Darnowski JW, Calabresi P.
    Cancer Chemother Pharmacol; 2004 Mar 15; 53(3):261-6. PubMed ID: 14658007
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats.
    Onoue M, Kurita A, Kado S, Matsumoto T, Kaneda N, Uchida K, Kato I, Yokokura T.
    Cancer Chemother Pharmacol; 2008 Apr 15; 61(4):595-605. PubMed ID: 17549477
    [Abstract] [Full Text] [Related]

  • 17. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
    Shinohara H, Killion JJ, Kuniyasu H, Kumar R, Fidler IJ.
    Clin Cancer Res; 1998 Sep 15; 4(9):2053-63. PubMed ID: 9748119
    [Abstract] [Full Text] [Related]

  • 18. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
    Melo ML, Brito GA, Soares RC, Carvalho SB, Silva JV, Soares PM, Vale ML, Souza MH, Cunha FQ, Ribeiro RA.
    Cancer Chemother Pharmacol; 2008 Apr 15; 61(5):775-84. PubMed ID: 17624531
    [Abstract] [Full Text] [Related]

  • 19. Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats.
    Fittkau M, Voigt W, Holzhausen HJ, Schmoll HJ.
    J Cancer Res Clin Oncol; 2004 Jul 15; 130(7):388-94. PubMed ID: 15160289
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.
    Rothenberg ML, Cox JV, DeVore RF, Hainsworth JD, Pazdur R, Rivkin SE, Macdonald JS, Geyer CE, Sandbach J, Wolf DL, Mohrland JS, Elfring GL, Miller LL, Von Hoff DD.
    Cancer; 1999 Feb 15; 85(4):786-95. PubMed ID: 10091755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.